Georgetown University LogoGeorgetown University Library LogoDigitalGeorgetown Home
    • Login
    View Item 
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Lombardi Comprehensive Cancer Center
    • Program of Tumor Biology
    • Graduate Theses and Dissertations - Tumor Biology
    • View Item
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Lombardi Comprehensive Cancer Center
    • Program of Tumor Biology
    • Graduate Theses and Dissertations - Tumor Biology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The role of the chemokine receptor CXCR4 in EGFRvIII-expressing breast cancer

    Cover for The role of the chemokine receptor CXCR4 in EGFRvIII-expressing breast
      cancer
    View/Open
    View/Open: rahimiMassod.pdf (4.0MB) Bookview

    Creator
    Rahimi, Massod.
    Description
    Thesis (Ph.D.)--Georgetown University, 2009.; Includes bibliographical references.; Text (Electronic thesis) in PDF format. The ligand-independent, constitutively active Epidermal Growth Factor Receptor (EGFR) variant, EGFRvIII, is a potent tumor-specific oncogene found in many human cancers, including breast cancer. EGFRvIII has various oncogenic functions, including enhancing breast cancer cell invasion, and its expression is correlated with disease progression and metastasis in human breast cancer.; Chemokines and their receptors are essential for normal development and physiology and are also involved in numerous human diseases, most importantly cancer progression and metastasis. CXCR4 has been extensively studied since its identification as a molecule involved in the "homing" of cancer cells to sites which express the CXCR4 cognate ligand, SDF-1 (CXCL12). ErbB2 enhances the expression of CXCR4, and was shown to be required for ErbB2-mediated invasion in vitro and lung metastasis in vivo, and co-expression of CXCR4 with both wild-type EGFR and ErbB2 has been shown to be correlated with an increased breast cancer metastases and poor prognosis. However, the impact of CXCR4 expression in the invasive phenotype of EGFRvIII-expressing breast cancer is unknown.; This study reveals that EGFRvIII increased expression of CXCR4 transcriptionally, and post-translationally by decreasing molecules involved in the internalization, recycling, cellular trafficking, and degradation of CXCR4 in breast cancer cells regardless of estrogen receptor status or endogenous levels of other ErbB-receptors. EGFRvIII-expressing breast cancer cells also had significantly higher CXCL12/CXCR4 mediated invasion in comparison to parental cells that have high levels of ErbB2, signifying an even more important role for CXCR4 in EGFRvIII-induced invasiveness. Suppression of CXCR4 expression in EGFRvIII-expressing breast cancer cells with short hair-pin RNA (shRNA) significantly inhibited breast cancer cell invasion and also decreased cell proliferation. Further investigation revealed that knocking-down CXCR4 expression decreased EGFRvIII expression by increasing EGFRvIII protein trafficking and subsequent degradation through increased activity of p38 MAPK. Finally, since the use of anti-EGFR targeted therapies in the clinic may be limited and EGFR mutants are often associated with resistance to conventional anticancer therapies, the well-tolerated natural, antitumor compound, 3,3'-Diindolylmethane (DIM) was shown to inhibit the invasion and proliferation of breast cancer, glioma, and lung cancer cells expressing EGFR mutants.
    Permanent Link
    http://hdl.handle.net/10822/553613
    Date Published
    2009
    Subject
    Biology, Cell; Biology, Molecular; Health Sciences, Oncology
    Type
    thesis
    Publisher
    Georgetown University
    Collections
    • Graduate Theses and Dissertations - Tumor Biology
    Metadata
    Show full item record

    Related items

    Showing items related by title, author, creator and subject.

    • Cover for THE ROLE OF NUCLEAR RECEPTOR COACTIVATOR AIB1/SRC3 IN NORMAL AND BREAST CANCER STROMAL FUNCTIONS

      THE ROLE OF NUCLEAR RECEPTOR COACTIVATOR AIB1/SRC3 IN NORMAL AND BREAST CANCER STROMAL FUNCTIONS 

      Al-Otaiby, Maram Abdulmohsen (Georgetown University, 2012)
      The nuclear receptor coactivator amplified in breast cancer 1 (AIB1/SRC3) has a well-defined role in steroid and growth factor signaling in cancer and normal epithelial cells. Less is known about its function in stromal ...
    Related Items in Google Scholar

    Georgetown University Seal
    ©2009 - 2023 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility
     

     

    Browse

    All of DigitalGeorgetownCommunities & CollectionsCreatorsTitlesBy Creation DateThis CollectionCreatorsTitlesBy Creation Date

    My Account

    Login

    Statistics

    View Usage Statistics

    Georgetown University Seal
    ©2009 - 2023 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility